tanshinone and Acute Promyelocytic Leukemia
tanshinone has been researched along with Acute Promyelocytic Leukemia in 19 studies
Research
Studies (19)
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 12 (63.16) | 29.6817 |
2010's | 6 (31.58) | 24.3611 |
2020's | 1 (5.26) | 2.80 |
Authors
Authors | Studies |
---|---|
Feng, N; Guo, T; Hou, X; Li, Z; Liu, W; Xia, Q; Zhang, Y; Zhu, C | 1 |
Chen, SJ | 1 |
Li, J; Meng, W; Xing, H; Yang, Y; Zhang, K | 2 |
Guo, L; Lei, CK; Shan, M | 1 |
Meng, WT; Yang, YM; Zhou, J | 1 |
Du, R; Meng, WT; Qin, H; Wang, YP; Yuan, SL; Zheng, H | 1 |
Li, L; Zhang, ZH; Zhao, WD | 1 |
Meng, WT; Yang, YM; Zhang, G; Zhou, J | 1 |
Gong, YP; Luo, S; Yang, L; Yang, YM | 1 |
Li, J; Meng, W; Yang, Y; Zhang, K | 1 |
Jia, Y; Liang, Y; Liu, T; Niu, T; Qin, H; Qin, P; Xu, C; Yang, Y; Yuan, S | 1 |
Cheng, Y; Deng, C; Jia, Y; Li, L; Liang, X; Liu, T; Meng, W; Yang, Y | 1 |
Huang, CL; Liu, ZG; Meng, WT; Yang, YM | 1 |
Fu, R; Jing, LP; Liang, Y; Qu, W; Song, WX; Wang, J; Wu, XZ | 1 |
Deng, CQ; Meng, WT; Yang, YM; Zhang, HL | 1 |
Huang, M; Huang, RW; Li, XD; Lin, DJ; Liu, JJ; Liu, PQ | 1 |
Liu, T; Yang, YM | 1 |
Jia, Y; Liang, Y; Liu, T; Meng, W; Yang, Y; Yuan, S | 1 |
Other Studies
19 other study(ies) available for tanshinone and Acute Promyelocytic Leukemia
Article | Year |
---|---|
Folic acid modified lipid-bilayer coated mesoporous silica nanoparticles co-loading paclitaxel and tanshinone IIA for the treatment of acute promyelocytic leukemia.
Topics: Abietanes; Animals; Antineoplastic Combined Chemotherapy Protocols; Cell Line, Tumor; Delayed-Action Preparations; Drug Carriers; Drug Delivery Systems; Drug Liberation; Female; Folic Acid; Humans; Leukemia, Promyelocytic, Acute; Lipid Bilayers; Mice; Mice, Inbred BALB C; Mice, Nude; Nanoparticles; Paclitaxel; Silicon Dioxide; Xenograft Model Antitumor Assays | 2020 |
A potential target of Tanshinone IIA for acute promyelocytic leukemia revealed by inverse docking and drug repurposing.
Topics: Abietanes; Binding Sites; Cell Line, Tumor; Cell Proliferation; Computer Simulation; Drug Repositioning; Drugs, Chinese Herbal; HL-60 Cells; Humans; Leukemia, Promyelocytic, Acute; Molecular Docking Simulation; Receptors, Retinoic Acid; Retinoic Acid Receptor alpha; Salvia miltiorrhiza | 2014 |
Tanshinone IIA inhibits acute promyelocytic leukemia cell proliferation and induces their apoptosis in vivo.
Topics: Abietanes; Animals; Antineoplastic Agents, Phytogenic; Apoptosis; Cell Differentiation; Cell Line, Tumor; Cell Proliferation; Female; Humans; Leukemia, Promyelocytic, Acute; Mice, SCID | 2016 |
[Study of growth inhibitory effect and apoptosis induced by different matches of Tanshinone IIA and Salvianolic Acid B on Acute Promyelocytic Leukemia cells (HL-60)].
Topics: Abietanes; Antineoplastic Agents, Phytogenic; Apoptosis; Benzofurans; Cell Proliferation; Drugs, Chinese Herbal; Flow Cytometry; HL-60 Cells; Humans; Leukemia, Promyelocytic, Acute; Phenanthrenes; Plants, Medicinal; Salvia miltiorrhiza | 2008 |
[Effect of tanshinone II A on NB4 cell induced procoagulant activity in human umbilical vein endothelial cells].
Topics: Abietanes; Blood Coagulation Factors; Cell Line, Tumor; Endothelial Cells; Humans; Leukemia, Promyelocytic, Acute; Phenanthrenes; Thromboplastin; Tretinoin; Umbilical Veins | 2009 |
[Study of molecular mechanism of tanshinone II A inducing differentiation in acute promyelocytic leukemia NB4 cells].
Topics: Abietanes; Cell Differentiation; Cell Line, Tumor; Drugs, Chinese Herbal; Gene Expression Regulation, Leukemic; Humans; Leukemia, Promyelocytic, Acute; Phenanthrenes | 2008 |
[Apoptosis of MR2 cells induced by Tanshinone II A combined with arsenic trioxide].
Topics: Abietanes; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Apoptosis; Arsenic Trioxide; Arsenicals; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cell Line, Tumor; Drug Resistance, Neoplasm; Drug Synergism; Humans; Leukemia, Promyelocytic, Acute; Oxides; Phenanthrenes; Tretinoin | 2009 |
[Apoptosis of NB4 cells induced by Tanshinone II A combined with arsenic trioxide].
Topics: Abietanes; Antineoplastic Agents; Apoptosis; Arsenic Trioxide; Arsenicals; Cell Line, Tumor; Cell Proliferation; Drug Synergism; Humans; Leukemia, Promyelocytic, Acute; Oxides | 2010 |
C/EBPβ and CHOP participate in tanshinone IIA-induced differentiation and apoptosis of acute promyelocytic leukemia cells in vitro.
Topics: Abietanes; Antineoplastic Agents, Phytogenic; Apoptosis; CCAAT-Enhancer-Binding Protein-beta; Cell Differentiation; Cell Line, Tumor; Gene Expression Regulation, Neoplastic; Humans; Leukemia, Promyelocytic, Acute; Phenanthrenes; Transcription Factor CHOP | 2010 |
[A successful case of tanshinone II A treatment for relapsed acute promyelocytic leukemia after maintainance therapy of all-trans retinoic acid and arsenic trioxide].
Topics: Abietanes; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Arsenic Trioxide; Arsenicals; Humans; Leukemia, Promyelocytic, Acute; Male; Mercaptopurine; Methotrexate; Neoplasm Recurrence, Local; Oxides; Tretinoin; Young Adult | 2010 |
Tanshinone IIA in acute promyelocytic leukemia.
Topics: Abietanes; Antineoplastic Agents, Phytogenic; Apoptosis; Blotting, Western; Cell Line; Drug Resistance, Neoplasm; Flow Cytometry; Humans; Leukemia, Promyelocytic, Acute; Microscopy, Electron, Transmission | 2012 |
[Terminal differentiation of human acute promyelocytic leukemia (APL) cells induced by Tanshinone II A in primary culture].
Topics: Abietanes; Antineoplastic Agents, Phytogenic; Cell Differentiation; Humans; Leukemia, Promyelocytic, Acute; Phenanthrenes; Tumor Cells, Cultured | 2000 |
[The variation of Caspase3 activity in tanshinone induced NB4 cells apoptosis].
Topics: Abietanes; Antineoplastic Agents, Phytogenic; Apoptosis; Caspase 3; Caspases; Humans; Leukemia, Promyelocytic, Acute; Phenanthrenes; Tumor Cells, Cultured | 2003 |
[Differentiation and apoptosis of NB4 cells synergistically induced by Tanshinone II A and all-trans retinoic acid].
Topics: Abietanes; Antineoplastic Agents, Phytogenic; Apoptosis; Cell Differentiation; Cell Line, Tumor; Drug Synergism; Drugs, Chinese Herbal; Humans; Leukemia, Promyelocytic, Acute; Phenanthrenes; Tretinoin | 2004 |
[A study on the cell differentiation induced by tanshinone IIA and its molecular mechanism in retinoic acid: resistant acute promyelocytic leukemia].
Topics: Abietanes; Antineoplastic Agents, Phytogenic; Cell Differentiation; Cell Line, Tumor; Cell Proliferation; Dose-Response Relationship, Drug; Drug Resistance, Neoplasm; Humans; Leukemia, Promyelocytic, Acute; Phenanthrenes; Tretinoin | 2005 |
[Effects of Tanshinone IIA on procoagulant activity of human ECV304 cell line induced by NB4 cells].
Topics: Abietanes; Anticoagulants; Cell Differentiation; Cell Line; Cell Line, Tumor; Culture Media, Conditioned; Drugs, Chinese Herbal; Endothelial Cells; Humans; Leukemia, Promyelocytic, Acute; Phenanthrenes; Thromboplastin; Tretinoin; Umbilical Veins | 2006 |
Induction of apoptosis and inhibition of cell adhesive and invasive effects by tanshinone IIA in acute promyelocytic leukemia cells in vitro.
Topics: Abietanes; Apoptosis; Caspase 3; Cell Adhesion; Cell Line, Tumor; Humans; Leukemia, Promyelocytic, Acute; Neoplasm Invasiveness; Phenanthrenes | 2006 |
[Complete remission of acute promyelocytic leukemia resisting all-trans retinoic acid of one case treated by tanshinone II A].
Topics: Abietanes; Adult; Drug Resistance, Neoplasm; Humans; Leukemia, Promyelocytic, Acute; Male; Phenanthrenes; Remission Induction; Tretinoin | 2006 |
[Acute promyelocytic leukemia cell differentiation induced by tanshinone II A and its molecular mechanism].
Topics: Abietanes; Cell Differentiation; Cell Division; Genes, p53; Humans; Leukemia, Promyelocytic, Acute; Phenanthrenes | 2000 |